Founders Capital Management buys $5,843,328 stake in DaVita HealthCare Partners Inc (DVA)

DaVita HealthCare Partners Inc (DVA) : Founders Capital Management scooped up 9,348 additional shares in DaVita HealthCare Partners Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 11, 2016. The investment management firm now holds a total of 91,732 shares of DaVita HealthCare Partners Inc which is valued at $5,843,328.DaVita HealthCare Partners Inc makes up approximately 3.29% of Founders Capital Management’s portfolio.

Other Hedge Funds, Including , Cutler Group Lp added DVA to its portfolio by purchasing 8,618 company shares during the most recent quarter which is valued at $548,967. DaVita HealthCare Partners Inc makes up approx 0.03% of Cutler Group Lp’s portfolio.New England Research Management reduced its stake in DVA by selling 825 shares or 16.26% in the most recent quarter. The Hedge Fund company now holds 4,250 shares of DVA which is valued at $272,468. DaVita HealthCare Partners Inc makes up approx 0.23% of New England Research Management’s portfolio.Norman Fields Gottscho Capital Management boosted its stake in DVA in the latest quarter, The investment management firm added 7,631 additional shares and now holds a total of 91,403 shares of DaVita HealthCare Partners Inc which is valued at $5,859,846. DaVita HealthCare Partners Inc makes up approx 3.90% of Norman Fields Gottscho Capital Management’s portfolio.

DaVita HealthCare Partners Inc closed down -1.7 points or -2.67% at $62 with 24,47,966 shares getting traded on Tuesday. Post opening the session at $63.61, the shares hit an intraday low of $61.95 and an intraday high of $63.61 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, DaVita HealthCare Partners Inc reported $1.01 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $0.98. The company had revenue of $3718.00 million for the quarter, compared to analysts expectations of $3658.91 million. The company’s revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.95 EPS.

Many Wall Street Analysts have commented on DaVita HealthCare Partners Inc. DaVita HealthCare Partners Inc was Upgraded by Raymond James to ” Outperform” on Sep 20, 2016. DaVita HealthCare Partners Inc was Downgraded by BofA/Merrill to ” Neutral” on Sep 6, 2016. DaVita HealthCare Partners Inc was Initiated by Citigroup to “Neutral” on Sep 6, 2016.

DaVita HealthCare Partners Inc. consists of two divisions Kidney Care and HealthCare Partners (HCP). Kidney Care is a provider of dialysis services in the United States treating patients with chronic kidney failure and end stage renal disease (ESRD). Kidney Care division develops innovative clinical care offers integrated treatment plans personalized care teams and health-management services. As of December 31 2014 we provided dialysis and administrative services in the U.S. through a network of 2179 outpatient dialysis centers in 46 states and the District of Columbia serving a total of approximately 173000 patients. HealthCare Partners division is a patient- and physician-focused integrated health care delivery and management company. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona California Nevada Florida and New Mexico. As of December 2014 HealthCare Partners had approximately 837000 members under its care.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

DaVita HealthCare Partners Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on DaVita HealthCare Partners Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.